About David Horn
Form D filings for Mid-Atlantic BioTherapeutics from 2018 to 2024 list David Horn as chief executive officer and director.
David Horn first appears on SEC filings in 2018.
Experience
This experience comes from SEC filings. The years are when the filings name David Horn in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people David Horn works with at each company, as listed on that company's latest Form D.
Mid-Atlantic BioTherapeutics, Inc. · Form D, Sep 30, 2024
JC
Julian Chick
Director
MG
Michael Goldblatt
Director
AK
Andrew Katz
Director
DJ
David Jobes
President and director
JG
Jean Pierre Gagnon
Director